In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Unigene announces receipt of milestone payment from Warner Lambert
Warner Lambert not to enter Synaptic collaboration second phase
Biosense signs collaboration with Warner-Lambert for gene therapy guided catheter
Pfizer signs letter of intent with Warner-Lambert to expand Lipitor agreement
Onyx and Warner-Lambert to jointly develop anticancer virus products
Warner-Lambert and American Home Products to merge
Catalytica to manufacture consumer healthcare products for Warner-Lambert
Xenon Genetics Awarded $4.7 million in Funding from Genome Canada and Genome BC
Xenon Genetics advances triglyceride drug discovery program
Xenon Enters Cardiovascular Disease Collaboration with Merck & Co., Inc.
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
